Expert Opinion on Biological Therapy
-
Publication Venue For
- Adenovirus vaccine immunotherapy targeting WT1-expressing tumors.. 10:875-883. 2010
- Countering tumor-induced immunosuppression during immunotherapy for pancreatic cancer.. 9:331-339. 2009
- Spontaneous and treatment-induced cancer rejection in humans.. 8:337-349. 2008
- CPG-7909 (PF-3512676, ProMune): toll-like receptor-9 agonist in cancer therapy.. 7:1257-1266. 2007
- Update on anti-CTLA-4 antibodies in clinical trials.. 7:1245-1256. 2007
- Vascular endothelial growth factor and immunosuppression in cancer: current knowledge and potential for new therapy.. 7:449-460. 2007
- Recent clinical progress in virus-based therapies for cancer.. 6:1123-1134. 2006
- Pegfilgrastim: a granulocyte colony-stimulating factor with sustained duration of action.. 5:1635-1646. 2005
- Virus-based therapies for colon cancer.. 5:1627-1633. 2005
- Infliximab for the treatment of early rheumatoid arthritis.. 5:405-417. 2005
- The colony-stimulating factors: use to prevent and treat neutropenia and its complications.. 4:1897-1910. 2004
- Regulatable aptamers in medicine: focus on antithrombotic strategies.. 4:1641-1647. 2004
- Monoclonal antibodies for brain tumour treatment.. 4:1453-1471. 2004